TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004
TCL Archive Patient Advocacy: Breast Cancer Coalition Forms PAC To Increase Political Activities April 18, 1997
TCL Archive NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year January 11, 1991
